Aminopeptidase A inhibitors

Citation
C. David-basei et al., Aminopeptidase A inhibitors, EXPERT OP T, 11(3), 2001, pp. 431-444
Citations number
52
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EXPERT OPINION ON THERAPEUTIC PATENTS
ISSN journal
13543776 → ACNP
Volume
11
Issue
3
Year of publication
2001
Pages
431 - 444
Database
ISI
SICI code
1354-3776(200103)11:3<431:AAI>2.0.ZU;2-0
Abstract
Potent and specific aminopeptidase A (APA, glutamylaminopeptidase, EC 3.4.1 1.7) inhibitors could be useful as powerful tools in the study of the physi ological involvement of this enzyme in the metabolism of various peptides. Thus, using newly designed selective APA inhibitors, APA has been shown to participate in the metabolism of cholecystokinin and to be responsible for the conversion of angiotensin II (Ang II), a peripheral vasoconstrictor pep tide, into Ang III, which has been recently shown to induce an increase in blood pressure and in vasopressin release in rat brain. Moreover, APA was s hown to be overexpressed in several types of malignant tumours, probably by inducing the formation of as yet unidentified cell proliferating active pe ptide(s). This review highlights advances in the structure and functions of APA and in the design of ver); potent and selective inhibitors of this zin c metallopeptidase. These compounds could have interesting applications in the treatment of essential hypertension and their usefulness in cancer chem otherapy warrants further investigations.